https://ir.definiumtx.com/ https://ir.definiumtx.com/news-events https://ir.definiumtx.com/news-events/press-releases https://ir.definiumtx.com/news-events/ir-calendar https://ir.definiumtx.com/news-events/presentations https://ir.definiumtx.com/news-events/email-alerts https://ir.definiumtx.com/about https://ir.definiumtx.com/about/contacts https://ir.definiumtx.com/about/faq https://ir.definiumtx.com/financial-results https://ir.definiumtx.com/stock-data/quote-chart https://ir.definiumtx.com/stock-data/historical-data https://ir.definiumtx.com/analyst-coverage https://ir.definiumtx.com/sec-filings https://ir.definiumtx.com/sec-filings/all-sec-filings https://ir.definiumtx.com/sec-filings/annual-reports https://ir.definiumtx.com/sec-filings/quarterly-reports https://ir.definiumtx.com/sec-filings/section-16-filings https://ir.definiumtx.com/corporate-governance https://ir.definiumtx.com/corporate-governance/board-committees https://ir.definiumtx.com/corporate-governance/governance-documents https://ir.definiumtx.com/news-events/press-releases/detail/219/new-definium-therapeutics-study-published-in-the-journal-of-mood-and-anxiety-disorders-reveals-increasing-prevalence-and-burden-of-generalized-anxiety-disorder-in-the-united-states 2026-03-31T07:00:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/218/definium-therapeutics-announces-new-employee-inducement-grants 2026-03-30T16:01:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/217/definium-therapeutics-to-host-investor-and-analyst-day-in-new-york-on-april-22-2026 2026-03-26T07:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/216/definium-therapeutics-announces-new-employee-inducement-grants 2026-03-09T16:01:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/215/definium-therapeutics-reports-full-year-2025-financial-results-and-business-updates 2026-02-26T16:01:02-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/214/definium-therapeutics-to-participate-at-upcoming-investor-conferences 2026-02-24T11:32:50-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/213/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026 2026-02-19T16:01:02-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/212/definium-therapeutics-announces-new-employee-inducement-grants 2026-02-02T16:00:01-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/211/definium-therapeutics-appoints-roger-adsett-to-board-of-directors 2026-01-29T07:00:02-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/210/definium-therapeutics-announces-new-employee-inducement-grants 2026-01-26T16:01:01-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/209/definium-therapeutics-introduces-rerouting-minds-an-educational-campaign-exploring-the-potential-of-pharmaceutical-lysergide-lsd-in-mental-health-care 2026-01-20T07:00:04-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/208/definium-therapeutics-common-shares-to-trade-under-new-nasdaq-ticker-symbol-dftx-effective-january-15-2026 2026-01-13T07:00:06-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/207/mindmed-rebrands-to-definium-therapeutics-advancing-a-leading-late-stage-psychiatry-pipeline-with-three-phase-3-readouts-expected-in-2026 2026-01-28T14:31:21-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/206/mindmed-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference 2025-12-18T07:01:00-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/205/mindmed-announces-new-employee-inducement-grant 2025-12-15T16:01:01-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/204/mindmed-announces-new-employee-inducement-grants 2025-12-01T16:01:01-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/203/mindmed-reports-q3-2025-financial-results-and-business-updates 2025-11-06T16:01:04-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/202/mindmed-to-participate-in-upcoming-investor-conferences 2025-11-05T07:01:03-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/201/mindmed-announces-new-employee-inducement-grant 2025-11-03T16:01:07-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/200/mind-medicine-mindmed-inc-announces-closing-of-approximately-259-million-public-offering-including-full-exercise-of-the-underwriters-option-to-purchase-additional-shares 2025-11-03T07:01:02-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/199/mindmed-to-report-q3-2025-financial-results-on-november-6-2025 2025-10-30T16:01:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/198/mind-medicine-mindmed-inc-announces-pricing-of-225-million-public-offering 2025-10-29T22:14:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/197/mind-medicine-mindmed-inc-announces-proposed-public-offering 2025-10-29T16:01:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/196/mindmed-announces-new-employee-inducement-grant 2025-10-14T16:01:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/195/mindmed-announces-new-employee-inducement-grants 2025-09-22T16:01:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/194/new-mindmed-retrospective-study-presented-at-psych-congress-2025-reveals-high-rates-of-suicidal-ideation-si-in-adults-with-generalized-anxiety-disorder-gad 2025-09-19T07:00:03-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/193/mindmed-announces-new-employee-inducement-grants 2025-09-08T16:01:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/192/journal-of-the-american-medical-association-jama-publishes-results-from-first-ever-randomized-placebo-controlled-clinical-trial-assessing-the-dose-dependent-efficacy-of-mm120-lysergide-d-tartrate-lsd-in-generalized-anxiety-disorder-gad 2025-09-04T11:05:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/191/mindmed-to-participate-in-september-investor-conferences 2025-08-28T07:00:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/190/mindmed-announces-new-employee-inducement-grants 2025-08-11T16:01:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/189/mindmed-reports-q2-2025-financial-results-and-business-updates 2025-07-31T16:01:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/188/mindmed-to-report-second-quarter-2025-financial-results-on-july-31-2025 2025-07-24T07:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/187/mindmed-announces-new-employee-inducement-grants 2025-07-14T16:01:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/186/mindmed-announces-new-employee-inducement-grants 2025-06-09T16:01:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/185/mindmed-to-participate-in-june-investor-conferences 2025-05-28T07:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/184/mindmed-strengthens-executive-team-with-appointment-of-brandi-roberts-cpa-as-chief-financial-officer 2025-05-27T07:00:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/183/mindmed-announces-new-employee-inducement-grants 2025-05-19T16:01:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/182/mindmed-to-present-at-the-2025-rbc-capital-markets-global-healthcare-conference 2025-05-13T07:00:04-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/181/mindmed-reports-first-quarter-2025-financial-results-and-recent-business-updates 2025-05-08T07:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/180/mindmed-to-report-first-quarter-2025-financial-results-on-may-8-2025 2025-04-24T07:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/179/mindmed-announces-new-employee-inducement-grants 2025-04-21T16:01:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/178/mindmed-announces-first-patient-dosed-in-phase-3-emerge-study-of-mm120-in-major-depressive-disorder-mdd 2025-04-15T07:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/177/mindmed-announces-new-employee-inducement-grants 2025-03-24T16:01:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/176/mindmed-appoints-matt-wiley-as-chief-commercial-officer 2025-03-17T09:21:52-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/175/mindmed-reports-fourth-quarter-and-full-year-2024-financial-results-and-recent-business-updates 2025-03-06T07:00:02-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/174/mindmed-to-present-at-leerinks-global-healthcare-conference-2025 2025-03-04T07:00:16-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/173/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025 2025-02-20T07:00:02-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/172/mindmed-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference 2025-02-04T07:00:01-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/171/mindmed-announces-first-patient-dosed-in-panorama-the-second-pivotal-phase-3-study-of-mm120-in-generalized-anxiety-disorder 2025-01-30T08:03:41-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/170/mindmed-to-be-added-to-the-nasdaq-biotechnology-index 2024-12-19T07:00:32-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/169/mindmed-announces-first-patient-dosed-in-phase-3-voyage-study-of-mm120-in-generalized-anxiety-disorder-gad 2024-12-16T07:36:07-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/168/mindmed-scientific-presentations-at-american-college-of-neuropsychopharmacology-acnp-2024-congress 2024-12-20T12:06:42-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/167/mindmed-awarded-innovation-passport-designation-by-the-united-kingdom-uk-innovative-licensing-and-access-pathway-ilap-steering-group-for-mm120-orally-disintegrating-tablet-odt-for-generalized-anxiety-disorder-gad 2024-12-05T07:00:01-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/166/mindmed-appoints-javier-muniz-m-d-as-vice-president-of-research-and-development-strategy 2024-12-03T07:07:27-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/165/mindmed-announces-new-employee-inducement-grants 2024-12-02T07:00:01-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/164/mindmed-appoints-gregg-pratt-ph-d-as-chief-regulatory-and-quality-assurance-officer 2024-11-18T07:08:46-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/163/mindmed-to-participate-in-upcoming-investor-conferences 2024-11-13T09:11:44-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/162/mindmed-reports-third-quarter-2024-financial-results-and-business-updates 2024-11-07T16:01:06-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/161/mindmed-to-host-conference-call-and-webcast-to-discuss-third-quarter-2024-financial-results-and-provide-business-update 2024-10-24T07:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/160/mindmed-announces-new-employee-inducement-grants 2024-09-09T16:01:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/159/mindmed-to-participate-in-september-investor-conferences 2024-09-04T07:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/158/mindmed-reports-second-quarter-2024-financial-results-and-business-updates 2024-08-13T07:00:05-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/157/mind-medicine-mindmed-inc-announces-pricing-of-public-offering 2024-08-09T08:44:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/156/mind-medicine-mindmed-inc-announces-proposed-public-offering 2024-08-09T06:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/155/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference 2024-08-06T16:01:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/154/mindmed-to-host-conference-call-and-webcast-to-discuss-second-quarter-2024-financial-results-and-provide-business-update 2024-08-06T07:00:08-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/153/mindmed-appoints-stephanie-fagan-as-chief-corporate-affairs-officer 2024-07-29T07:00:05-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/152/mindmed-announces-issuance-of-new-patent-for-mm120-orally-disintegrating-tablet-odt 2024-07-17T07:00:17-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/151/mindmed-to-be-included-in-russell-2000-and-russell-3000-indexes 2024-06-28T07:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/150/mindmed-to-present-at-the-h-c-wainwright-5th-annual-neuro-perspectives-virtual-conference 2024-06-21T07:00:00-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/149/mindmed-announces-constructive-end-of-phase-2-meeting-with-u-s-fda-for-mm120-in-generalized-anxiety-disorder-gad 2024-06-20T07:00:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/148/mindmed-to-participate-in-june-conferences 2024-05-28T07:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/147/mindmed-to-participate-at-may-investor-conferences 2024-05-09T16:01:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/146/new-studies-presented-at-the-international-society-for-health-economics-and-outcomes-research-meeting-ispor-24-show-growing-burden-and-impact-of-generalized-anxiety-disorder-gad-in-the-us 2024-05-09T11:42:44-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/145/mindmed-reports-first-quarter-2024-financial-results-and-business-updates 2024-05-08T19:12:41-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/144/mindmed-presents-phase-2b-study-of-mm120-for-generalized-anxiety-disorder-gad-at-american-psychiatric-association-apa-annual-meeting-in-new-york 2024-05-04T08:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/143/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2024-financial-results-and-provide-business-update 2024-05-02T07:00:13-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/142/mindmed-to-present-at-upcoming-may-medical-conferences 2024-04-25T07:00:03-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/141/mindmed-to-present-at-upcoming-april-medical-conferences 2024-04-02T07:00:03-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/140/mindmed-announces-voluntary-delisting-from-cboe-canada 2024-04-01T17:00:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/139/mindmed-to-participate-in-the-leerink-partners-2024-global-biopharma-conference 2024-03-11T07:00:05-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/138/mind-medicine-mindmed-inc-announces-pricing-of-underwritten-offering-of-common-shares-and-concurrent-private-placement 2024-03-07T07:13:01-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/137/mindmed-receives-fda-breakthrough-therapy-designation-and-announces-positive-12-week-durability-data-from-phase-2b-study-of-mm120-for-generalized-anxiety-disorder 2024-03-07T06:00:02-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/136/mindmed-to-host-conference-call-and-webcast-to-discuss-data-update-for-mm120 2024-03-01T09:00:01-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/135/mindmed-reports-2023-financial-results-and-business-updates 2024-02-28T07:05:01-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/134/mindmed-to-host-conference-call-and-webcast-to-discuss-2023-financial-results-and-provide-business-update 2024-02-22T07:00:03-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/133/mindmed-to-participate-in-the-34th-annual-oppenheimer-healthcare-life-sciences-conference 2024-02-07T07:00:08-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/132/mindmed-announces-business-update-and-anticipated-milestones-for-2024 2024-01-08T07:45:01-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/131/mindmed-announces-positive-topline-results-from-phase-2b-trial-of-mm-120-in-generalized-anxiety-disorder 2023-12-14T07:30:02-05:00 https://ir.definiumtx.com/news-events/press-releases/detail/130/mindmed-reports-third-quarter-2023-financial-results-and-business-highlights 2023-11-02T16:01:03-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/129/mindmed-to-host-conference-call-and-webcast-to-discuss-third-quarter-2023-financial-results-and-provide-business-update 2023-10-26T07:30:00-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/128/mindmed-completes-enrollment-of-phase-2a-trial-of-mm-120-in-adults-with-attention-deficithyperactivity-disorder-adhd 2023-10-24T07:30:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/127/mindmed-to-present-data-on-the-preclinical-activity-of-mm-402-at-the-36th-annual-european-college-of-neuropsychopharmacology-ecnp-congress 2023-10-03T07:30:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/126/mindmed-to-participate-in-the-td-cowen-3rd-annual-novel-mechanisms-in-neuropsychiatry-summit 2023-09-14T07:30:00-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/125/mindmed-completes-enrollment-of-phase-2b-trial-of-mm-120-in-generalized-anxiety-disorder-gad 2023-09-12T07:30:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/124/mindmed-to-participate-at-september-investor-conferences 2023-08-28T07:30:00-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/123/mindmed-secures-50-0-million-credit-facility-with-k2-healthventures 2023-08-14T07:30:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/122/mindmed-reports-second-quarter-2023-financial-results-and-business-highlights 2023-08-03T16:01:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/121/mindmed-announces-exclusive-license-agreement-with-catalent-for-its-patented-zydis-fast-dissolve-technology-for-use-with-mm-120 2023-08-03T07:30:05-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/120/mindmed-to-host-conference-call-and-webcast-to-discuss-second-quarter-2023-financial-results-and-provide-business-update 2023-07-31T08:30:00-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/5/mindmed-to-participate-in-the-h-c-wainwright-4th-annual-neuropsychiatry-virtual-conference 2023-07-14T16:57:55-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/6/mindmed-announces-election-of-all-six-company-nominees-at-annual-meeting 2023-07-14T16:57:56-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/7/mindmed-provides-overview-of-clinical-progress-and-corporate-updates-at-investor-day 2023-07-14T16:57:56-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/8/mindmed-adjourns-annual-general-meeting-of-shareholders 2023-07-14T16:57:56-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/107/mindmed-urges-shareholders-to-vote-today-for-company-nominees-ahead-of-june-13th-deadline 2023-07-14T16:58:34-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/9/leading-proxy-advisory-firm-glass-lewis-recommends-mindmed-shareholders-vote-for-all-six-company-nominees 2023-07-14T16:57:57-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/10/mindmed-to-host-investor-day-june-2023 2023-07-14T16:57:57-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/108/leading-proxy-advisory-firm-iss-recommends-mindmed-shareholders-vote-for-all-six-company-nominees 2023-07-14T16:58:34-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/11/mindmed-to-participate-at-upcoming-investor-conferences 2023-07-14T16:57:57-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/12/mindmed-releases-investor-presentation-highlighting-how-the-company-is-unlocking-the-power-of-psychedelics-for-patients-and-shareholders 2023-07-14T16:57:57-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/13/mindmed-publishes-report-by-leading-fda-experts-validating-mindmeds-mm-120-drug-development-strategy 2023-07-14T16:57:58-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/109/mindmed-to-present-data-on-the-preclinical-activity-of-mm-402-at-the-american-society-of-clinical-psychopharmacology-ascp-2023-annual-meeting 2023-07-14T16:58:36-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/110/mindmed-announces-enrollment-milestone-in-phase-2b-trial-of-mm-120-in-generalized-anxiety-disorder-gad 2023-07-14T16:58:36-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/111/mindmed-reports-first-quarter-2023-financial-results-and-business-highlights 2023-07-14T16:58:37-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/112/mindmed-sends-letter-to-shareholders-highlighting-companys-positive-momentum-and-value-enhancing-strategy 2023-07-14T16:58:37-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/14/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update 2023-07-14T16:57:58-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/113/mindmed-to-participate-in-may-investor-conferences 2023-07-14T16:58:38-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/114/mindmed-files-preliminary-proxy-statement-for-2023-annual-meeting 2023-07-14T16:58:38-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/115/mindmed-collaborators-announce-positive-topline-data-from-phase-2-trial-of-lysergide-lsd-in-major-depressive-disorder-mdd 2023-07-14T16:58:39-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/116/mindmed-appoints-mark-r-sullivan-as-chief-legal-officer-and-corporate-secretary 2023-07-14T16:58:39-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/117/mindmed-reports-full-year-2022-financial-results-and-business-highlights 2023-07-14T16:58:39-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/118/mindmed-to-participate-in-march-investor-conferences 2023-07-14T16:58:39-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/15/mindmed-provides-corporate-update-and-2023-outlook 2023-07-14T16:57:59-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/16/mindmed-to-participate-in-the-canaccord-genuity-new-paradigms-and-treatment-approaches-in-mental-health-conference 2023-07-14T16:57:59-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/17/mindmed-to-participate-in-the-jefferies-london-healthcare-conference 2023-07-14T16:57:59-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/18/mindmed-reports-third-quarter-2022-financial-results-and-business-highlights 2023-07-14T16:58:00-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/19/mindmed-to-host-earnings-call-to-discuss-third-quarter-2022-financial-results-and-provide-business-update 2023-07-14T16:58:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/20/mindmed-to-participate-in-the-cantor-fitzgerald-neurology-psychiatry-conference 2023-07-14T16:58:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/21/mindmed-collaborators-initiate-phase-1-comparative-pkpd-trial-of-r--s--and-racemic-mdma 2023-07-14T16:58:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/22/mindmed-announces-pricing-of-public-offering-of-common-shares-and-warrants 2023-07-14T16:58:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/23/mindmed-announces-proposed-public-offering-of-common-shares 2023-07-14T16:58:01-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/24/mindmed-collaborators-dose-first-patient-in-phase-1-investigator-initiated-trial-of-mdma-like-substances 2023-07-14T16:58:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/25/mindmed-announces-compliance-with-nasdaq-listing-requirements 2023-07-14T16:58:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/26/mindmed-announces-positive-results-from-collaborators-placebo-controlled-investigator-initiated-trial-published-in-peer-reviewed-journal 2023-07-14T16:58:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/27/mindmed-to-participate-in-h-c-wainwright-global-investment-conference 2023-07-14T16:58:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/28/mindmed-completes-1-for-15-reverse-share-split 2023-07-14T16:58:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/29/mindmed-announces-first-patient-dosed-in-phase-2b-trial-of-mm-120-in-generalized-anxiety-disorder 2023-07-14T16:58:02-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/30/mindmed-strengthens-board-with-appointment-of-two-new-independent-directors 2023-07-14T16:58:03-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/31/mindmed-reports-second-quarter-2022-financial-results-and-business-highlights 2023-07-14T16:58:03-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/32/mindmed-board-of-directors-approves-reverse-share-split 2023-07-14T16:58:04-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/33/mindmed-to-host-earnings-call-to-discuss-second-quarter-2022-financial-results-and-provide-business-update 2023-07-14T16:58:04-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/34/mindmed-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference 2023-07-14T16:58:04-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/35/mindmed-announces-completion-of-share-redesignation 2023-07-14T16:58:04-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/36/mindmed-announces-voting-results-for-annual-general-and-special-meeting 2023-07-14T16:58:05-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/37/mindmed-to-participate-in-the-jefferies-global-healthcare-conference 2023-07-14T16:58:05-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/38/mindmed-appoints-schond-l-greenway-as-chief-financial-officer 2023-07-14T16:58:05-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/39/mindmed-reports-topline-data-from-phase-1-trial-of-mm-110-in-development-for-the-treatment-of-opioid-withdrawal 2023-07-14T16:58:05-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/40/mindmed-announces-at-the-market-offering 2023-07-14T16:58:05-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/41/mindmed-reports-first-quarter-2022-financial-results-and-business-highlights 2023-07-14T16:58:05-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/42/mindmed-to-host-key-opinion-leader-webinar-on-substance-use-disorders-and-withdrawal-management 2023-07-14T16:58:06-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/43/mindmed-collaborators-prof-liechti-and-dr-holze-announce-positive-topline-data-from-phase-2-trial-evaluating-lsd-in-anxiety-disorders 2023-07-14T16:58:06-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/44/mindmed-to-host-earnings-call-to-discuss-first-quarter-2022-financial-results-and-provide-business-update 2023-07-14T16:58:06-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/45/mindmed-collaborator-dr-matthias-liechti-to-present-topline-clinical-trial-results-for-lsd-in-anxiety-disorders-at-psych-symposium 2023-07-14T16:58:06-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/46/mindmed-appoints-francois-lilienthal-md-as-chief-commercial-officer 2023-07-14T16:58:06-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/47/mindmed-reports-proposed-change-in-auditor-for-2022-fiscal-year 2023-07-14T16:58:07-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/48/mindmed-reports-full-year-2021-financial-results-and-business-highlights 2023-07-14T16:58:07-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/49/mindmed-announces-transition-of-cfo 2023-07-14T16:58:07-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/50/mindmed-to-host-earnings-call-to-discuss-full-year-2021-financial-results-and-provide-business-update 2023-07-14T16:58:08-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/51/mindmed-to-participate-in-march-investor-conferences 2023-07-14T16:58:08-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/52/mindmed-announces-publication-of-study-comparing-the-acute-effects-of-lysergic-acid-diethylamide-and-psilocybin-in-healthy-subjects 2023-07-14T16:58:08-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/53/mindmed-converts-multiple-voting-shares-to-subordinate-voting-shares 2023-07-14T16:58:08-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/54/fda-clears-mindmed-ind-for-mm-120-in-treatment-of-generalized-anxiety-disorder 2023-07-14T16:58:09-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/55/mindmed-enrolls-first-participant-in-a-study-of-its-session-monitoring-system 2023-07-14T16:58:09-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/56/stephen-hurst-resigns-from-mindmed-board-of-directors 2023-07-14T16:58:09-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/57/mindmed-successfully-completes-phase-1-clinical-trial-of-18-mc 2023-07-14T16:58:09-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/58/mindmed-to-participate-at-the-lifesci-partners-11th-annual-corporate-access-event 2023-07-14T16:58:10-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/59/mindmed-announces-transitions-to-management-team 2023-07-14T16:58:10-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/60/mindmed-provides-status-update-on-ind-for-phase-2b-trial-of-lsd-for-the-treatment-of-generalized-anxiety-disorder 2023-07-14T16:58:10-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/61/mindmed-initiates-phase-2a-lsd-trial-for-the-treatment-of-adult-adhd 2023-07-14T16:58:10-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/62/mindmed-appoints-robert-barrow-as-chief-executive-officer-and-director 2023-07-14T16:58:10-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/63/mindmed-engages-in-productive-pre-submission-meeting-with-fda-for-development-of-the-mindmed-session-monitoring-system 2023-07-14T16:58:11-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/64/mindmed-to-participate-at-the-benzinga-global-small-cap-conference 2023-07-14T16:58:11-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/65/mindmed-to-present-at-h-c-wainwright-2nd-annual-psychedelics-conference 2023-07-14T16:58:11-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/66/mindmed-and-liechti-lab-publish-first-human-data-on-the-interacting-effects-of-an-ssri-and-psilocybin 2023-07-14T16:58:11-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/67/mindmed-launches-study-of-low-dose-lsd-effects-on-sleep-and-cognitive-measures 2023-07-14T16:58:11-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/68/mindmed-announces-financial-results-for-the-third-quarter-2021-and-business-highlights-cash-balance-of-145-9-usd-185-4-cad-to-execute-on-diverse-clinical-pipeline 2023-07-14T16:58:12-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/69/mindmed-to-present-at-the-jefferies-london-healthcare-conference 2023-07-14T16:58:12-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/70/mindmed-appoints-dr-maria-oquendo-to-its-scientific-advisory-board 2023-07-14T16:58:12-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/71/mindmed-to-present-at-web-summit-on-future-of-mental-health 2023-07-14T16:58:13-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/72/mindmed-expands-its-drug-development-pipeline-with-launch-of-r--mdma-program 2023-07-14T16:58:13-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/73/mindmed-cmo-to-chair-digital-biomarkers-summit 2023-07-14T16:58:14-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/74/mindmed-joins-clinical-trials-transformation-initiative 2023-07-14T16:58:15-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/75/mindmed-announces-strategic-research-collaboration-with-sphere-health 2023-07-14T16:58:15-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/76/mindmed-announces-appointment-of-andreas-krebs-and-carol-vallone-as-directors-and-transition-of-bruce-linton 2023-07-14T16:58:16-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/77/mindmed-appoints-university-of-north-carolina-psychiatrist-and-pharmacologist-dr-bryan-roth-to-scientific-advisory-board 2023-07-14T16:58:16-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/78/mindmed-to-present-at-the-benzinga-healthcare-small-cap-conference 2023-07-14T16:58:16-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/79/mindmed-and-liechti-lab-provide-results-from-their-psilocybin-rd-collaboration 2023-07-14T16:58:17-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/80/mindmed-announces-participation-at-upcoming-investor-conferences 2023-07-14T16:58:17-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/81/mindmed-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference 2023-07-14T16:58:17-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/82/mindmed-to-attend-8th-annual-mobile-in-clinical-trials-conference 2023-07-14T16:58:18-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/83/mindmed-and-bioxcel-therapeutics-publish-an-international-patent-application-describing-a-system-for-identifying-agitation-episodes 2023-07-14T16:58:18-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/84/mindmed-announces-collaboration-with-forian-to-advance-development-of-personalized-psychiatry-for-anxiety-disorders 2023-07-14T16:58:19-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/85/mindmed-joins-critical-path-institutes-patient-reported-outcome-consortium 2023-07-14T16:58:19-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/86/mindmed-announces-2021-q2-financial-results-cash-balance-of-157-usd-million-195-cad-million-to-execute-on-diverse-clinical-pipeline 2023-07-14T16:58:19-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/87/mindmed-appoints-dr-robert-dworkin-to-scientific-advisory-board 2023-07-14T16:58:19-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/119/mindmed-joins-digital-medicine-society-to-improve-health-outcomes-and-equity-using-technology 2023-07-14T16:58:53-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/88/mindmed-announces-initiation-of-phase-1-clinical-trial-of-intravenous-dmt 2023-07-14T16:58:20-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/89/mindmed-chosen-to-participate-in-cowens-psychedelics-novel-mechanisms-in-neuropsychiatry-virtual-summit 2023-07-14T16:58:21-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/90/mindmed-announces-partnership-with-datavant-a-leading-health-data-connectivity-company 2023-07-14T16:58:21-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/91/mindmed-included-in-ftse-russell-3000-index 2023-07-14T16:58:22-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/92/mindmed-appoints-mgh-psychiatrist-in-chief-dr-maurizio-fava-to-scientific-advisory-board 2023-07-14T16:58:22-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/93/mindmed-appoints-pharmaceutical-veteran-peter-bergethon-m-d-to-scientific-advisory-board 2023-07-14T16:58:23-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/94/mindmed-announces-chief-executive-officer-transition 2023-07-14T16:58:23-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/95/mindmed-announces-shareholder-meeting-results 2023-07-14T16:58:24-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/96/mindmed-and-liechti-lab-in-basel-switzerland-publish-first-pharmacogenetic-data-on-lsd-to-help-guide-personalized-dosing 2023-07-14T16:58:24-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/97/mindmed-announces-launch-of-collaboration-with-nextage-therapeutics-brain-targeting-liposome-system 2023-07-14T16:58:25-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/98/mindmed-announces-the-approval-of-mescaline-study 2023-07-14T16:58:25-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/99/the-chopra-foundation-and-mindmed-enter-into-letter-of-intent-to-partner-on-the-future-of-psychedelic-medicines-mental-wellbeing 2023-07-14T16:58:25-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/100/mindmed-receives-fda-type-c-meeting-response-for-project-lucy-phase-2b-clinical-trial 2023-07-14T16:58:26-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/101/mindmed-announces-appointment-of-dr-sarah-y-vinson-as-additional-director 2023-07-14T16:58:26-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/102/mindmed-announces-2021-q1-financial-results-cash-balance-of-160m-usd-194m-cad-to-execute-on-diverse-clinical-pipeline 2023-07-14T16:58:26-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/103/mindmed-bolsters-management-team-appoints-peter-mack-phd-as-vice-president-of-pharmaceutical-development 2023-07-14T16:58:27-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/104/mindmed-announces-project-angie-targeting-the-treatment-of-pain-with-psychedelics 2023-07-14T16:58:27-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/105/mindmed-begins-trading-on-nasdaq 2023-07-14T16:58:27-04:00 https://ir.definiumtx.com/news-events/press-releases/detail/106/mindmed-to-commence-trading-on-nasdaq 2023-07-14T16:58:28-04:00 https://ir.definiumtx.com/news-events/ir-calendar/detail/20260422-definium-therapeutics-investor-analyst-day 2026-03-26T07:01:47-04:00 https://ir.definiumtx.com/news-events/ir-calendar/detail/20260317-stifel-2026-virtual-cns-forum 2026-02-24T07:03:14-05:00 https://ir.definiumtx.com/news-events/ir-calendar/detail/20260311-leerink-partners-global-healthcare-conference 2026-02-24T07:03:10-05:00 https://ir.definiumtx.com/news-events/ir-calendar/detail/20260302-td-cowen-46th-annual-health-care-conference 2026-03-03T11:26:13-05:00 https://ir.definiumtx.com/news-events/ir-calendar/detail/20260226-q4-2025-earnings-conference-call 2026-02-19T17:41:34-05:00 https://ir.definiumtx.com/news-events/ir-calendar/detail/20260114-44th-annual-j-p-morgan-healthcare-conference 2026-01-14T18:30:14-05:00 https://ir.definiumtx.com/news-events/ir-calendar/detail/20251106-q3-2025-earnings-conference-call 2025-11-20T19:20:06-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-126830/ownership.html 2026-03-26T18:44:01-04:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-126827/ownership.html 2026-03-26T18:43:15-04:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-126825/ownership.html 2026-03-26T18:42:39-04:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001950047-26-003007/primary_doc.html 2026-03-25T17:41:47-04:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001950047-26-003006/primary_doc.html 2026-03-25T17:41:02-04:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001950047-26-003005/primary_doc.html 2026-03-25T17:40:26-04:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-076742/dftx-20251231.htm 2026-02-26T16:36:39-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-076612/dftx-20260226.htm 2026-02-26T16:18:32-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001831942-26-000006/primary_doc.html 2026-02-17T16:22:50-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0000938206-26-000012/primary_doc.html 2026-02-17T09:22:51-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0000902664-26-001011/primary_doc.html 2026-02-17T09:01:55-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001172661-26-000710/primary_doc.html 2026-02-13T08:43:08-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-039598/ownership.html 2026-02-05T17:02:26-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-039585/ownership.html 2026-02-05T16:58:07-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-039579/ownership.html 2026-02-05T16:56:23-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-039576/ownership.html 2026-02-05T16:55:27-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-039571/ownership.html 2026-02-05T16:53:50-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-029915/ownership.html 2026-01-29T20:36:41-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-029913/ownership.html 2026-01-29T20:35:03-05:00 https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-028186/dftx-20260128.htm 2026-01-29T07:30:58-05:00 https://ir.definiumtx.com/news-events/presentations/detail/23397/mm120-for-generalized-anxiety-disorder-gad-phase-2b-full-topline-data-odt-pk-bridging-study-breakthrough-therapy-designation 2024-03-07T00:00:00-05:00 https://ir.definiumtx.com/news-events/presentations/detail/23523/corporate-presentation-february-2026 2026-02-26T00:00:00-05:00 https://ir.definiumtx.com/disclaimer https://ir.definiumtx.com/sitemap https://ir.definiumtx.com/accessibility-statement